Colon Cancer
📧 Sign up to get email alerts when something new happens for Colon Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-01-16Clinical Trial Update: Does Genetic Susceptibility for Bleeding Affect Quantitative Faecal Immunochemical Test (qFIT) Results?
The clinical trial evaluating whether genetic susceptibility to bleeding affects quantitative faecal immunochemical test (qFIT) results for …
-
CLINICAL_TRIALS withdrawal · 2024-11-26Clinical Trial Update: Effectiveness of Aquatic Exercise on Fatigue, Neuropathy and Quality of Life Among Cancer Patients [NA]
A clinical trial evaluating aquatic exercise for fatigue, neuropathy, and quality of life in colon and breast cancer patients has been withd…
-
CLINICAL_TRIALS withdrawal · 2024-11-21Clinical Trial Update: Botensilimab, Balstilimab and Regorafenib or Botensilimab and Balstilimab for the Treatment of Advanced or Metastatic Microsatellite Stable Colorectal Cancer [Phase 2]
A Phase 2 clinical trial evaluating Botensilimab and Balstilimab with or without Regorafenib for microsatellite-stable advanced or metastati…
-
CLINICAL_TRIALS withdrawal · 2024-09-20Clinical Trial Update: Immunoscore As Decision Guidance for Adjuvant Chemotherapy in Colon Cancer [Phase 3]
A Phase 3 trial evaluating Immunoscore-based guidance for adjuvant chemotherapy in Stage III colon cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Tucatinib Combined with Trastuzumab and TAS-102 for the Treatment of HER2 Positive Metastatic Colorectal Cancer in Molecularly Selected Patients, 3T Study [Phase 2]
A Phase 2 trial evaluating tucatinib in combination with trastuzumab and TAS-102 for HER2-positive metastatic colorectal cancer in molecular…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-08-09Clinical Trial Update: Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors [EARLY_Phase 1]
A Phase 1 trial evaluating phytocannabinoids for chemotherapy-induced peripheral neuropathy in breast and colon cancer survivors has been wi…
-
CLINICAL_TRIALS withdrawal · 2024-07-31Clinical Trial Update: Pembrolizumab in Early Stage Colon Cancer [Phase 2]
The Phase 2 trial of pembrolizumab for early-stage colon cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-06-13Clinical Trial Update: GI Organ Tracking Via Balloon Applicators [NA]
A clinical trial evaluating GI organ tracking via balloon applicators sponsored by Washington University School of Medicine has been withdra…
-
CLINICAL_TRIALS withdrawal · 2024-04-29Clinical Trial Update: Regorafenib and XmAb20717 in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy (RX-CROME) [Phase 2]
A Phase 2 trial RX-CROME evaluating regorafenib with XmAb20717 for high-risk colorectal cancer patients with radiographic occult molecular r…
-
CLINICAL_TRIALS withdrawal · 2023-12-04Clinical Trial Update: Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections [Phase 3]
Phase 3 trial investigating viscosity of submucosal gel injections for endoscopic mucosal resection was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-06-01Clinical Trial Update: Assessing the Safety and Performance of the Endoscopic Linear Cutter Stapler and Reloads (Frankenman) in Colectomy
A clinical trial evaluating the Endoscopic Linear Cutter Stapler and reloads (Frankenman) for colectomy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-05-30Clinical Trial Update: Eniluracil Hand Foot Syndrome [Phase 1]
The Phase 1 trial of eniluracil for breast cancer and colon cancer was terminated.
-
CLINICAL_TRIALS withdrawal · 2018-04-09Clinical Trial Update: Early Palliative Care Integration in Interventional Cancer Care [NA]
University of Miami-sponsored trial (NCT03185416) evaluating early palliative care integration in interventional cancer care has been withdr…
-
CLINICAL_TRIALS withdrawal · 2018-03-22Clinical Trial Update: Mechanistic Prehabilitation [NA]
A mechanistic prehabilitation trial (NCT01919541) involving colon and rectal cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors [Phase 1]
A Phase 1 trial evaluating CT-011 and a p53 genetic vaccine for advanced solid tumors was withdrawn; the study encompassed breast cancer, co…
-
CLINICAL_TRIALS withdrawal · 2017-01-25Clinical Trial Update: Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal Cancer [Phase 2]
Phase II study of Zaltrap (aflibercept) with chemotherapy for advanced resectable colorectal cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-12-01Clinical Trial Update: A Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer [Phase 1, Phase 2]
Trial NCT01522677 evaluating neoadjuvant photodynamic immunomodulation for colon cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-09-15Clinical Trial Update: Regional Anesthesia in Colon Rectal Surgery [NA]
A clinical trial on regional anesthesia for colon cancer surgery has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-05-20Clinical Trial Update: Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer [Phase 1, Phase 2]
This document reports the withdrawal of a Phase 1/2 trial evaluating BGJ398 (infigratinib), an FGFR kinase inhibitor, in combination with ch…
-
CLINICAL_TRIALS withdrawal · 2015-05-06Clinical Trial Update: Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer [Phase 2]
A Phase 2 clinical trial evaluating Ziv-Aflibercept with fluorouracil and leucovorin for Stage IV colorectal cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-03-17Clinical Trial Update: Single Port Laparoscopic Colectomy [Phase 1, Phase 2]
A Phase 1/Phase 2 trial of single port laparoscopic colectomy for colon cancer led by the University of British Columbia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-01-17Clinical Trial Update: Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer [EARLY_Phase 1]
An early-phase 1 trial evaluating cholecalciferol (25-[OH]-Vitamin D) for colorectal cancer was withdrawn and did not proceed.
-
CLINICAL_TRIALS withdrawal · 2013-07-10Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Colon Cancer [Phase 2]
A Phase 2 trial of antineoplaston therapy for Stage IV colon cancer and recurrent colon cancer conducted by the Burzynski Research Institute…
-
CLINICAL_TRIALS withdrawal · 2013-01-03Clinical Trial Update: Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver [Phase 2]
A Phase 2 trial investigating Yttrium-90 microspheres combined with cetuximab and irinotecan for advanced colorectal cancer with liver metas…
-
CLINICAL_TRIALS withdrawal · 2012-05-28Clinical Trial Update: Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers
A clinical trial on collection of biospecimens and clinical information from patients with gastrointestinal and gynecologic cancers was with…